13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001920938
Total reported value
$2.7B
$2.7B
73 檔
36.8%
During the Q3 2025 filing period, Braidwell LP (CIK: 0001920938) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $2.7B across 73 reported positions.
Braidwell LP executed strategic sector rebalancing during Q3 2025, establishing 28 new positions while fully exiting 19 holdings and trimming 22 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GH 1.25 02-15-31Bond | Guardant Health Inc | Bond | 8.49% | -3.42% | EXIT | |
| 2 | CAI | Caris Life Sciences Inc | Stock-Other | 6.57% | +0.66% | — | |
| 3 | NVCR 0 11-01-25Bond | Novocure LTD | Bond | 6.23% | — | +50.08% | |
| 4 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 4.29% | -0.07% | — | |
| 5 | CGON | Cg Oncology Inc | Stock-Other | 3.92% | -2.22% | EXIT | |
| 6 | NBIX | Neurocrine Biosciences Inc | Stock-Healthcare | 3.67% | -0.77% | -24.14% | |
| 7 | RGEN 1 12-15-28Bond | Repligen CORP | Bond | 3.02% | -2.68% | — | |
| 8 | KRYS | Krystal Biotech Inc | Stock-Healthcare | 2.73% | +0.20% | -28.50% | |
| 9 | NUVL | Nuvalent Inc-a | Stock-Other | 2.60% | -2.39% | EXIT | |
| 10 | NEO 0.25 01-15-28Bond | Neogenomics Inc | Bond | 2.58% | -2.44% | -0.99% | |
| 11 | SLNOEUR | Soleno Therapeutics Inc | Stock-Other | 2.57% | -1.07% | EXIT | |
| 12 | IRTC 1.5 09-01-29Bond | Irhythm Holdings Inc | Bond | 2.53% | — | -11.43% | |
| 13 | EWTX | Edgewise Therapeutics Inc | Stock-Other | 2.51% | +0.53% | — | |
| 14 | IRWD 1.5 06-15-26Bond | Ironwood Pharmaceuticals | Bond | 2.16% | — | -11.43% | |
| 15 | INSP | Inspire Medical Systems Inc | Stock-Healthcare | 1.95% | -0.05% | +69.17% | |
| 16 | GKOS | Glaukos CORP | Stock-Healthcare | 1.89% | +0.32% | +29.29% | |
| 17 | DHR | Danaher CORP | Stock-Healthcare | 1.82% | +0.18% | — | |
| 18 | LEGN | Legend Biotech Corp-adr | Stock-Other | 1.77% | — | -28.16% | |
| 19 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 1.73% | -0.16% | +45.34% | |
| 20 | APGE | Apogee Therapeutics Inc | Stock-Other | 1.70% | -1.34% | EXIT | |
| 21 | ARGX | Argenx Se - Adr | Stock-Healthcare | 1.67% | -1.46% | -60.88% | |
| 22 | TMO | Thermo Fisher Scientific Inc | Stock-Healthcare | 1.64% | +0.14% | -15.75% | |
| 23 | ALGN | Align Technology Inc | Stock-Healthcare | 1.52% | — | -17.52% | |
| 24 | ACAD | Acadia Pharmaceuticals Inc | Stock-Healthcare | 1.51% | -0.30% | — | |
| 25 | HNGE | Hinge Health Inc-a | Stock-Other | 1.33% | +2.21% | — | |
| 26 | SYRE | Spyre Therapeutics Inc | Stock-Other | 1.28% | +1.32% | — | |
| 27 | TMDX | Transmedics Group Inc | Stock-Healthcare | 1.17% | +0.41% | +37.72% | |
| 28 | IRTC | Irhythm Holdings Inc | Stock-Healthcare | 1.15% | +0.48% | -24.73% | |
| 29 | PEN | Penumbra Inc | Stock-Healthcare | 1.06% | -1.15% | EXIT | |
| 30 | KPTI 6 05-13-29 *Bond | Karyopharm Therapeutics | Bond | 1.04% | — | — | |
| 31 | DYN | Dyne Therapeutics Inc | Stock-Other | 1.02% | -0.26% | -16.58% | |
| 32 | CVS | Cvs Health CORP | Stock-Healthcare | 0.98% | -0.70% | EXIT | |
| 33 | DNTH | Dianthus Therapeutics Inc | Stock-Other | 0.97% | -0.38% | — | |
| 34 | CDNA | Caredx Inc | Stock-Other | 0.94% | +0.03% | — | |
| 35 | BMRN | Biomarin Pharmaceutical Inc | Stock-Healthcare | 0.85% | -0.94% | EXIT | |
| 36 | GMED | Globus Medical Inc - A | Stock-Healthcare | 0.85% | — | +101.46% | |
| 37 | ORKA | Oruka Therapeutics Inc | Stock-Other | 0.79% | +0.98% | NEW | |
| 38 | RGEN | Repligen CORP | Stock-Healthcare | 0.78% | +0.70% | +35.35% | |
| 39 | KNSA | Kiniksa Pharmaceuticals International, plc | Stock-Other | 0.74% | -0.01% | -41.67% | |
| 40 | THC | Tenet Healthcare CORP | Stock-Healthcare | 0.73% | — | — | |
| 41 | MRVI | Maravai Lifesciences Hldgs-a | Stock-Other | 0.71% | +1.04% | — | |
| 42 | EXK | Exact Sciences CORP | Stock-Materials | 0.67% | — | — | |
| 43 | AKRO | Akero Therapeutics Inc | Stock-Other | 0.67% | — | — | |
| 44 | ATEC | Alphatec Holdings Inc | Stock-Other | 0.65% | +1.30% | -58.33% | |
| 45 | KIDS | Orthopediatrics CORP | Stock-Other | 0.61% | +0.20% | — | |
| 46 | VKTX | Viking Therapeutics Inc | Stock-Healthcare | 0.59% | — | -47.17% | |
| 47 | CSTL | Castle Biosciences Inc | Stock-Other | 0.56% | — | — | |
| 48 | DRUG | Bright Minds Biosciences Inc | Stock-Other | 0.55% | -0.05% | — | |
| 49 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 0.53% | — | — | |
| 50 | HROW | Harrow Inc | Stock-Other | 0.49% | -0.18% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | NVCR 0 11-01-25Bond | Novocure LTD | +1.4% | +50.08% | Add |
| 2 | XENE | Xenon Pharmaceuticals Inc | +1.1% | — | Add |
| 3 | CGON | Cg Oncology Inc | +1.1% | — | Unchanged |
| 4 | DNTH | Dianthus Therapeutics Inc | +0.7% | — | Add |
| 5 | EWTX | Edgewise Therapeutics Inc | +0.6% | — | Add |
| 6 | GH 1.25 02-15-31Bond | Guardant Health Inc | +0.5% | — | Unchanged |
| 7 | NUVL | Nuvalent Inc-a | +0.5% | -13.85% | Add |
| 8 | RGEN | Repligen CORP | +0.4% | +35.35% | Add |
| 9 | CSTL | Castle Biosciences Inc | +0.3% | — | Add |
| 10 | INSP | Inspire Medical Systems Inc | +0.3% | +69.17% | Add |
| 11 | ORKA | Oruka Therapeutics Inc | +0.2% | -9.34% | Trim |
| 12 | ✓ | Zura Bio LTD | +0.2% | — | Unchanged |
| 13 | ISRG | Intuitive Surgical Inc | +0.2% | +45.34% | Add |
| 14 | KRYS | Krystal Biotech Inc | +0.2% | -28.50% | Add |
| 15 | MRVI | Maravai Lifesciences Hldgs-a | +0.1% | — | Unchanged |
| 16 | PEN | Penumbra Inc | 0% | +9.18% | Add |
| 17 | SRPT | Sarepta Therapeutics Inc | -0.1% | — | Add |
| 18 | LUNG | Pulmonx CORP | -0.1% | — | Unchanged |
| 19 | REPL | Replimune Group Inc | -0.2% | +550.31% | Add |
| 20 | SYRE | Spyre Therapeutics Inc | -0.2% | — | Unchanged |
| 21 | XNCR | Xencor Inc | -0.2% | -24.73% | Trim |
| 22 | DXCM 0.25 11-15-25Bond | Dexcom Inc | -0.2% | -27.03% | Trim |
| 23 | GKOS | Glaukos CORP | -0.3% | +29.29% | Add |
| 24 | DYN | Dyne Therapeutics Inc | -0.3% | -16.58% | Trim |
| 25 | APGE | Apogee Therapeutics Inc | -0.3% | -2.69% | Trim |
| 26 | KIDS | Orthopediatrics CORP | -0.4% | — | Unchanged |
| 27 | RGEN 1 12-15-28Bond | Repligen CORP | -0.4% | — | Add |
| 28 | HROW | Harrow Inc | -0.4% | -60.75% | Trim |
| 29 | DHR | Danaher CORP | -0.4% | — | Unchanged |
| 30 | NEO 0.25 01-15-28Bond | Neogenomics Inc | -0.5% | -0.99% | Trim |
| 31 | DAWNGBX | Day One Biopharmaceuticals I | -0.5% | — | Trim |
| 32 | TMO | Thermo Fisher Scientific Inc | -0.6% | -15.75% | Trim |
| 33 | IRTC 1.5 09-01-29Bond | Irhythm Holdings Inc | -0.6% | -11.43% | Trim |
| 34 | VKTX | Viking Therapeutics Inc | -0.6% | -47.17% | Trim |
| 35 | IRWD 1.5 06-15-26Bond | Ironwood Pharmaceuticals | -0.7% | -11.43% | Trim |
| 36 | KNSA | Kiniksa Pharmaceuticals International, plc | -0.8% | -41.67% | Trim |
| 37 | TMDX | Transmedics Group Inc | -0.9% | +37.72% | Trim |
| 38 | ATEC | Alphatec Holdings Inc | -0.9% | -58.33% | Trim |
| 39 | IRTC | Irhythm Holdings Inc | -0.9% | -24.73% | Trim |
| 40 | ADPT | Adaptive Biotechnologies | -0.9% | -80.95% | Trim |
| 41 | NBIX | Neurocrine Biosciences Inc | -1% | -24.14% | Trim |
| 42 | IMCR 2.5 02-01-30Bond | Immunocore Holdings | -1.4% | -74.55% | Trim |
| 43 | ALGN | Align Technology Inc | -1.4% | -17.52% | Trim |
| 44 | ARGX | Argenx Se - Adr | -1.7% | -60.88% | Trim |
| 45 | LEGN | Legend Biotech Corp-adr | -1.8% | -28.16% | Trim |
| 46 | CAI | Caris Life Sciences Inc | — | NEW | New buy |
| 47 | SLNOEUR | Soleno Therapeutics Inc | — | NEW | New buy |
| 48 | BBIO 2.5 03-15-27Bond | Bridgebio Pharma Inc | — | EXIT | Sold out |
| 49 | GH | Guardant Health Inc | — | EXIT | Sold out |
| 50 | ACAD | Acadia Pharmaceuticals Inc | — | NEW | New buy |
According to official SEC Form 13F filings, Braidwell LP reported a total U.S. public equity portfolio value of $2.7B across 73 disclosed positions in Q3 2025.
During Q3 2025, Braidwell LP's top holdings by market value included GH 1.25 02-15-31 (8.5%)、CAI (6.6%)、NVCR 0 11-01-25 (6.2%). The largest single position, GH 1.25 02-15-31, represented 8.5% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including GH 1.25 02-15-31, CAI, NVCR 0 11-01-25) accounted for 36.8% of total reported equity market value during Q3 2025.
Top New Position Initiated
CAI
市值: $221.3M
Top Position Liquidated / Trimmed
BBIO 2.5 03-15-27
前期市值: $72.0M
In Q3 2025, Braidwell LP made 84 total portfolio adjustments, initiating 28 new buys, adding to 15 positions, trimming 22 holdings, and fully liquidating 19 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.